| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Breast Cancer |
Michigan State University, Department of Medicine, Division of Hematology/Oncology, East Lansing, Michigan, USA
Key Words. Hormone • Endocrine • Male breast cancer
Correspondence: Nikolay V. Dimitrov, M.D., Michigan State University, B413 Clinical Center, East Lansing, Michigan 48824, USA. Telephone: 517-353-3128; Fax: 517-432-9471; e-mail: dimitrov{at}msu.edu
The management of hormone-dependent male breast cancer is insufficiently understood by practicing oncologists. This article provides a review of the endocrine profile of male breast cancer, and outlines the differences between hormone-dependent female and male breast cancers. A concise review of the past, present, and possible future management of hormone-dependent male breast cancer is presented. For a better understanding of this disease, more information on the natural history and biological behaviors of patients with male breast cancer is needed. This could be accomplished by the development of a specific multi-institutional tumor registry and execution of prospective clinical trials.
Disclosure of potential conflicts of interest is found at the end of this article.
This article has been cited by other articles:
![]() |
J. R. de la Haba Rodriguez, I. Porras Quintela, G. Pulido Cortijo, M. Berciano Guerrero, and E. Aranda Fulvestrant in advanced male breast cancer Ann. Onc., November 1, 2009; 20(11): 1896 - 1897. [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| THE ONCOLOGIST | STEM CELLS | CME | ALPHAMED PRESS JOURNALS |